|
|
| |
| Articles
by
Lalit Singh |
Total Records (
1 ) for
Lalit Singh |
|
 |
| |
|
| |
Amit Kumar Verma
,
Amit Kumar
,
Shanker Kumar Singh
,
Anu Rahal
,
Iftekhar Ahmed
,
Deepti Singh
,
Aashish Pratap Singh
and
Lalit Singh
|
| |
Globally, Campylobacters have been reported as leading
cause of gastroenteritis in man as well as animals and considered as emerging
zoonotic problem particularly in developing countries including India. A cross-sectional
study was conducted to know the prevalence and epidemiological determinants
for Campylobacter spp. in dogs in and around Mathura city, Uttar Pradesh,
India. Based on isolation, cultural and biochemical characterization of bacteria,
the prevalence of Campylobacter spp. was 34.24%. Younger dogs (less than
1 year of age) were more likely to carry Campylobacter spp. High prevalence
of Campylobacter spp. supports the hypothesis that dogs, particularly
younger animals, may be an important source of Campylobacter infection
for humans. Breed-wise prevalence showed that non-descript dogs (45.97%) were
more likely to carry Campylobacter infections. Dogs showing clinical
signs of gastroenteritis were showing higher prevalence (47.21%) in comparison
to that of animals without gastro-intestinal disorders (15.04%). Out of 113
Campylobacter isolates of canine origin, two isolates were resistant
to all the nineteen antibiotics used in the study, while all the isolates were
resistant to Streptomycin, Ampicillin, Amoxycillin, Aztreonam, Lincomycin, Tetracyclin,
Oxytetracyclin and Penicillin. A high rate of resistance was observed to Cefotaxim
(97.35%), Peefloxacin (91.15%), Chloramphenicol (90.27%), Ofloxacin (84.07%),
Ciprofloxacin (83.18%), Cefaclor (80.53%), Nitrofurazone (76.11%), Norfloxacin
(74.33%), Gentamicin (42.48%), Amikacin (40.71%) and Enrofloxacin (36.28%).
Our results indicate Amikacin and Gentamicin as drugs suitable for the treatment
of campylobacteriosis in dogs. |
|
|
|
|
| |
|
